Status:
UNKNOWN
18F-NaF PET in Detecting Metastatic Bone Lesion for Patients With Cancer.
Lead Sponsor:
National Taiwan University Hospital
Collaborating Sponsors:
Far Eastern Memorial Hospital
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
18F ion is a positron emitting bone radiopharmaceuticals. The skeletal uptake of 18F relies on the exchange of hydroxyl ions in the hydroxyapatit crystal which is an indicator of bone metabolic activi...
Detailed Description
Skeletal metastases are the most common cause of morbidity and mortality in patients with malignancy, especially in patients with breast cancer, lung cancer, prostate cancer and head \& neck cancer. I...
Eligibility Criteria
Inclusion
- pathology proofed lung cancer and are referred to perform whole-body bone scintigraphies for staging metastatic bone diseases
Exclusion
- patients whose age are below 18
- pregnant women
Key Trial Info
Start Date :
October 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00414934
Start Date
October 1 2006
End Date
December 1 2010
Last Update
August 17 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100